Evaluation of Potential Phototoxicity Skin Reaction After Use of MC2-01 Cream

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 27, 2019

Primary Completion Date

March 9, 2019

Study Completion Date

March 9, 2019

Conditions
Phototoxicity
Interventions
DRUG

MC2-01 Cream, irradiation

One application of MC2-01 Cream, followed by irradiation. Visual evaluation of application site using a visual scale that rated the degree of erythema, edema and other signs of cutaneous irritation

DRUG

MC2-01 Cream, no irradiation

One application of MC2-01 Cream. Visual evaluation of application site using a visual scale that rated the degree of erythema, edema and other signs of cutaneous irritation

DRUG

MC2-01 vehicle, irradiation

One application of MC2-01 vehicle, followed by irradiation. Visual evaluation of application site using a visual scale that rated the degree of erythema, edema and other signs of cutaneous irritation

DRUG

MC2-01 vehicle, no irradiation

One application of MC2-01 vehicle. Visual evaluation of application site using a visual scale that rated the degree of erythema, edema and other signs of cutaneous irritation

DRUG

Control, irradiation

Untreated, irradiated site. Visual evaluation of application site using a visual scale that rated the degree of erythema, edema and other signs of cutaneous irritation

Trial Locations (1)

07410

TKL Research Inc, Fair Lawn

Sponsors

Lead Sponsor

All Listed Sponsors
lead

MC2 Therapeutics

INDUSTRY